Announcements

David C. Longren, a director of Zurn Elkay Water Solutions Corp (NYSE: ZWS), acquired 604 shares of common stock on July 15, 2026, according to an insider activity disclosure filed with the Securities and Exchange Commission. The acquisition resulted from the vesting of restricted …

Happen Inc. CEO and Director Scott Sanborn executed a sale of 28,750 shares of common stock on July 15, 2026, at a weighted-average price of $20.078 per share, according to a regulatory filing. The transaction was conducted under a Rule 10b5-1 trading plan designed …

GS Finance Corp., a subsidiary of The Goldman Sachs Group, Inc., has filed a preliminary pricing supplement for a new structured note offering linked to the EURO STOXX 50 Index. The notes, expected to mature on August 4, 2031, provide investors with 2 times …

Repligen Corporation's Chief Financial Officer Jason Garland sold 530 shares of common stock on July 16, 2026, at $150 per share as part of a pre-established Rule 10b5-1 trading plan adopted in December 2025. The transaction, disclosed in a regulatory update filed July 17, …

Clover Health Investments Corp., the Medicare Advantage insurer trading on NASDAQ under ticker CLOV, disclosed an equity transaction by Jamie L. Reynoso, the company's Chief Executive Officer overseeing Medicare Advantage operations. According to a Form 4 update filed on July 17, 2026, Reynoso sold …

Marc Grandisson, Executive Chairman of Vantage at Howard Hughes Holdings Inc., received a significant restricted stock award on July 15, 2026, according to a regulatory filing with the Securities and Exchange Commission. The disclosure reveals that Grandisson acquired 68,653 shares of common stock through …

Howard Hughes Holdings Inc. disclosed on July 16, 2026, a leadership transition at Vantage Group Holdings Ltd., a subsidiary or affiliated entity within its portfolio. The announcement was made through a public press release filed with the Securities and Exchange Commission. The specifics of …